Screener
ImmunityBio, Inc. IBRX EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 7:37 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326110-26-000059
FAQ
- What is ImmunityBio, Inc.'s EPS (basic)?
- ImmunityBio, Inc. (IBRX) reported EPS (basic) of -$0.62 in Q1 2026.
- How has ImmunityBio, Inc.'s EPS (basic) changed year-over-year?
- ImmunityBio, Inc.'s EPS (basic) decreased by 313.3% year-over-year, from -$0.15 to -$0.62.
- What is the long-term trend for ImmunityBio, Inc.'s EPS (basic)?
- Over 4 years (2021 to 2025), ImmunityBio, Inc.'s EPS (basic) has grown at a -19.2% compound annual growth rate (CAGR), from -$0.89 to -$0.38.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about ImmunityBio, Inc.'s eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude